Arteris (NASDAQ:AIP) CEO Sells $41,422.68 in Stock

Arteris, Inc. (NASDAQ:AIP) CEO K Charles Janac sold 2,756 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $15.03, for a total transaction of $41,422.68. Following the completion of the sale, the chief executive officer directly owned 9,349,071 shares of the company’s stock, valued at approximately $140,516,537.13. This represents a 0.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

K Charles Janac also recently made the following trade(s):

• On Monday, February 9th, K Charles Janac sold 47,244 shares of Arteris stock. The stock was sold at an average price of $15.21, for a total value of $718,581.24.
• On Thursday, January 15th, K Charles Janac sold 17,884 shares of Arteris stock. The stock was sold at an average price of $17.84, for a total value of $319,050.56.
• On Tuesday, January 13th, K Charles Janac sold 2,116 shares of Arteris stock. The shares were sold at an average price of $17.79, for a total value of $37,643.64.
• On Thursday, January 8th, K Charles Janac sold 50,000 shares of Arteris stock. The shares were sold at an average price of $16.58, for a total value of $829,000.00.
• On Tuesday, January 6th, K Charles Janac sold 11,145 shares of Arteris stock. The stock was sold at an average price of $16.90, for a total value of $188,350.50.
• On Friday, January 2nd, K Charles Janac sold 7,823 shares of Arteris stock. The shares were sold at an average price of $15.45, for a total value of $120,865.35.
• On Monday, December 8th, K Charles Janac sold 70,000 shares of Arteris stock. The stock was sold at an average price of $17.71, for a total value of $1,239,700.00.
• On Friday, December 5th, K Charles Janac sold 60,000 shares of Arteris stock. The stock was sold at an average price of $17.08, for a total transaction of $1,024,800.00.
• On Thursday, December 4th, K Charles Janac sold 40,000 shares of Arteris stock. The shares were sold at an average price of $16.46, for a total transaction of $658,400.00.
• On Wednesday, December 3rd, K Charles Janac sold 2,058 shares of Arteris stock. The stock was sold at an average price of $15.52, for a total transaction of $31,940.16.

Arteris Price Performance

NASDAQ AIP opened at $14.62 on Friday. Arteris, Inc. has a 12 month low of $5.46 and a 12 month high of $19.85. The company has a market capitalization of $638.60 million, a P/E ratio of -17.83 and a beta of 1.47. The company’s 50 day simple moving average is $16.23 and its 200 day simple moving average is $13.27.

Arteris (NASDAQ:AIP) last issued its earnings results on Thursday, February 12th. The company reported ($0.05) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. The business had revenue of $20.14 million for the quarter, compared to the consensus estimate of $18.55 million. On average, analysts anticipate that Arteris, Inc. will post -0.73 earnings per share for the current year.

Key Stories Impacting Arteris

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Q4 2025 results beat expectations: EPS of ($0.05) topped estimates and revenue of $20.14M beat consensus; management issued above‑consensus revenue guidance for Q1 and FY‑2026 — a clear fundamental positive supporting upside. Read More.
• Positive Sentiment: Commercial traction: Arteris reported its network‑on‑chip technology has shipped in over 4 billion devices, a credibility milestone that supports longer‑term revenue expansion in AI and edge markets. Read More.
• Positive Sentiment: Strategic moves: Management outlined a >$100M contract‑value target for 2026 and strengthened chip security capability via the Cycuity acquisition — both bolster the company’s addressable market and product offering. Read More.
• Positive Sentiment: Analyst/institutional support: Rosenblatt reaffirmed a Buy and $20 PT; several funds increased or initiated positions recently, which provides bench‑marked upside versus the current price.
• Neutral Sentiment: Earnings materials and call transcripts are available for deeper read‑throughs — these will be sources of further guidance detail and management color that could move shares. Read More.
• Neutral Sentiment: Short‑interest data in feeds is inconsistent (entries showing 0/NaN vs earlier reported short positions), so short‑squeeze risk is unclear until exchanges reconcile figures.
• Negative Sentiment: Large insider/major‑holder selling: CEO K. Charles Janac (and major holder Bayview Legacy, LLC) sold sizeable blocks in recent days (47,244 shares on Feb 9 plus additional sales), creating added supply and pressuring sentiment. Read More.
• Negative Sentiment: Mixed research view: some shops (Weiss) remain negative; consensus is a Hold with a $17.50 average target — divergent analyst views can increase short‑term volatility.

Institutional Trading of Arteris

Institutional investors have recently made changes to their positions in the stock. Raymond James Financial Inc. acquired a new position in Arteris in the 2nd quarter valued at approximately $32,000. BNP Paribas Financial Markets increased its stake in shares of Arteris by 75.0% in the third quarter. BNP Paribas Financial Markets now owns 6,053 shares of the company’s stock worth $61,000 after acquiring an additional 2,595 shares during the last quarter. Savant Capital LLC acquired a new position in shares of Arteris in the second quarter worth $97,000. Strs Ohio purchased a new stake in shares of Arteris during the first quarter worth $104,000. Finally, Penn Capital Management Company LLC acquired a new stake in Arteris during the third quarter valued at $109,000. 64.36% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on AIP shares. Rosenblatt Securities reiterated a “buy” rating and issued a $20.00 price target on shares of Arteris in a research report on Friday. TD Cowen reaffirmed a “buy” rating on shares of Arteris in a research note on Wednesday, November 5th. Jefferies Financial Group raised shares of Arteris to a “hold” rating in a research report on Tuesday, October 28th. Weiss Ratings restated a “sell (d-)” rating on shares of Arteris in a report on Wednesday, January 21st. Finally, Northland Securities set a $24.00 price objective on shares of Arteris in a research note on Friday. Three analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $20.17.

Arteris Company Profile

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.